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Gliomas are the most common and aggressive form of 
primary malignant tumors of the central nervous system (1). 
According to the World Health Organization (WHO) 
classification, gliomas are classified in four malignant 
grades (I to IV), based on their histological (e.g., cellularity, 
anaplastic, necrosis, and microvascular proliferation) and 
molecular (e.g., IDH1/2 mutations, 1p/19q deletions and 
ATRX expression) features. Glioblastomas (WHO grade 
IV) are the most aggressive subtype, with a mean survival of 
16 months, and account for 50% of all gliomas (2). 
To further understand the complex pathogenesis of 
glioblastoma, recent studies have amplified their focus 
on non-coding RNAs (ncRNAs).  ncRNAs are key 
elements playing a central role in cellular development 
and homeostasis, and included several members, such as 
lncRNAs, circular RNAs (circRNAs) and miRNAs (3,4). 
Less than 2% of the total genome encodes protein-coding 
genes, suggesting that ncRNAs represent most of the 
human transcriptome, yet its role in cancer in general and 
gliomas in particular is poorly explored (5,6). 
circRNAs were originally identified in plant viroids (7). 
Thereafter, other researchers found circRNA structures in 
yeast mitochondrial RNAs (8) and hepatitis delta virus (9). 
CircRNAs are a subtype of ncRNAs that are generally 
composed of >200 nucleotides (10). Differing from the 
linear RNAs, circRNAs are formed by a covalently closed 
loop structures that lacks 5′-3′ ends and a poly A tail (10), 
which render circRNAs more stable than linear RNA and 
more resistant to degradation by RNA exonuclease or 
RNase R (11,12).
circRNAs are widely expressed in eukaryotic cells and 
are verified to participate in regulating transcriptional 
and post-transcriptional gene expression (13). Moreover, 
previous studies have indicated that circRNAs may serve 
as miRNA molecular “sponges”, which play critical roles 
in several diseases (10). It was showed that Cdr1as/ciRS-7 
affects miR-7 target gene activity by binding miR-7 as a 
miRNA sponge (10,13). Lately, a report showed that cir-
ZNF609 may act as a sponge for miR-150-5p illustrating 
that cir-ZNF609 took part in the onset of Hirschsprung 
disease through the crosstalk with AKT3 by competing for 
shared miR-150-5p (14).
Some studies have associated circRNAs disruption with 
human tumorigenesis and may be potential biomarkers and 
therapeutic targets for cancer treatment (15,16). However, 
the overall role of circRNAs remain uncertain. 
In a recent publication, Yang and co-authors from 
Zhang’s group from Sun Yat-Sen University, elegantly 
addressed the role of FBXW7 circular RNA in brain tumor 
(Figure 1). The authors showed that circ-FBXW7 expression 
was lower in glioma than normal brains and established a 
novel protein encoded by circ-FBXW7, FBXW7-185 aa, 
that suppresses glioma cell proliferation and the cell cycle. 
To identify this novel protein, the putative open reading 
frame (ORF) in circ-FBXW7 was evaluated and it was 
observed a potential spanning junction ORF that encoded 
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a 185 aa protein in circ-FBXW7. This ORF is considered 
highly conserved among different species, implying its 
translation in human cells. To confirm these findings, a set 
of vectors was established and transfected into 293T cells. 
The results showed a translocation of 22 kDa protein in 
circ-FBXW7-transfected cells, suggesting that FBXW7-
185 aa is formed by the “spanning junction ORF” (17). 
Then, the effects of FBXW7-185 aa on glioma cells and 
the molecular mechanism were evaluated and results 
showed that upregulation of FBXW7-185 aa in cancer cells 
repressed proliferation and cell cycle, while knockdown of 
FBXW7-185 aa promoted malignant phenotypes in vitro 
and in vivo (17).
FBXW7 have been shown to be strongly associated with 
tumorigenesis and loss of FBXW7 in cancer may have several 
effects on the critical cellular regulators, thereby controlling 
essential processes, such as cell cycle, differentiation, 
and apoptosis (18). Wei and colleagues also showed a 
decrease in FBXW7 expression level in breast cancer 
compared to the normal breast tissues, and the lower level 
of FBXW7 expression was related to shorter survival (19). 
Importantly, cancer genome consortiums and datasets, such 
as TCGA (The Cancer Genome Atlas), ICGC (International 
Cancer Genome Consortium) and COSMIC (Catalogue of 
Somatic Mutations in Cancer), highlighted the relative high 
frequency of FBXW7 mutation as a major cause of FBXW7 
aberrant expression in cancer.
Interestingly, the Zhang’s group also observed that 
upregulation of FBXW7-185 aa in cancer cells repressed 
proliferation and cell cycle and diminished the half-
life of c-Myc by antagonizing USP28-induced c-Myc 
stabilization. This outstanding circRNAs, FBXW7-185 
aa, showed to be as “multiple safe assurances” to control 
cellular proliferation (17). These novel evidences are in 
agreement with a previous study where it was shown that 
FBXW7 is functioning as the tumor suppressor against 
several cell cycle promoters, including MYC (18). Based in 
these findings, Yang and colleagues have also shown that 
glioblastoma patients with higher circ-FBXW7 had an 
increased total survival time compared with those with low 
circ-FBXW7 expression (17). 
Although Zhang’s group provides clear evidence that 
circRNA encodes functional protein in vivo, the clinical 
application of FBXW7-185 aa still has a long way to 
go. Hence, the clinical significance of circ-FBXW7 and 
FBXW7-185 aa may also need to be addressed in larger 
cohorts. The thorough cataloging of molecular regulatory 
mechanisms across the whole spectrum of gliomas affords 
the basis for new therapeutic development. Mackay and 
colleagues performed integrated molecular meta-analysis in 
the resource cohort of >1,000 cases of pediatric high-grade 
glioma and diffuse intrinsic pontine glioma. They identify 
Figure 1 The circ-FBXW7 is formed by circularization of exon 3 and exon 4 of the FBXW7 gene, which encode a 185 aa protein in circ-
FBXW7. Upregulation of FBXW7-185 aa in glioma cells inhibits proliferation and cell cycle acceleration, as well as reduces the half-life of 
c-Myc by antagonizing USP28-induced c-Myc stabilization. Glioma cells with higher circ-FBXW7 has an increase of total survival time.
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co-segregating mutations in histone-mutant subgroups 
including loss of FBXW7 in H3.3G34R/V, and show that 
histone wild-type subgroups are molecularly more similar 
to lower-grade tumors (20). These findings greatly extended 
the knowledge for biological study and provided a basis for 
new potential therapeutic targets.
Concluding, the work published by Yang et al. in 
J Natl Cancer Inst have provided novel and important role 
of FBXW7 circular RNA in suppressing human glioma, 
which may have a potential prognostic implication 
in glioma carcinogenesis and provides the basis for 
novel therapeutic development. Therefore, with the 
improvements in our understanding of the molecular 
mechanisms in gliomas, it is believed that functions of 
several circRNAs in disease will be determined, providing 
evidences for the future application of circRNAs in the 
diagnosis, prognosis and treatment of multiple types of 
cancer.
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